Socius Capital Group, a landmark in the world of investments

Socius Capital Group, a passive investor, has proven that while economy might be a mixture of technique and luck, in the case of this company risk is not an option.

New York, NY (prHWY.com) March 6, 2013 - Socius Capital Group is a professional investor, determined to help small companies lacking in capital to continue all research sessions. The economic crisis has undoubtedly affected the well workings of society, making things develop in a more difficult manner. Socius Capital Group works on the basics of encouraging evolution and for this reason, this company is determined to discover high potential and explore it in the benefit of society itself. Considering the opinion of recognized specialists in this domain, investments and financing activities are just the right tools to use in case the global market seems to be confronted with a harsh economic situation. A careful analysis of the work conducted by Socius Capital Group will point out the advantages the global economic environment has had. With a high interest in sectors like healthcare, life sciences, natural resources, technology, social media, Socius Capital Group injects capital where it is needed.

What sets this group apart from other of its kind is that the intention is not to occupy a place in the decision board. Being a passive investor, Socius Capital Group seeks no control position allowing the small companies to take their own decision regarding production, testing trials and marketing strategies. Therefore, there will be no transformations in the internal organization as a result of a partnership with Socius Capital Group. As mentioned in the beginning, a clear line between luck and skills must be drawn and this investor group has managed to accomplish just that. Socius Capital Group has a trained eye for successful small companies, which can turn out to profitable. Advanced Cell Technology and Cell Therapeutics are just two names linked to Socius Capital Group. These small companies have managed to continue their work and go against the economic crisis as a result of the investments made by Socius Capital Group. Advanced Cell Technology is a biotechnology company striving to find adequate treatment solutions for several illness. With the help of the above mentioned investor group, Advanced Cell technology was able to continue its research as a result of a $ 25 million capital. Cell Therapeutics is a biopharmaceutical company attempting to develop a life saving cure for people suffering from cancer. Without the capital provided by Socius Capital Group, this company would have totally ceased its activity.

Socius Capital Group does not accept capital from third parties, therefore it cannot be considered a hedge fond. Established in 2004, this company has a solid reputation on the financing and investing market, being widely considered a true help for small, but efficient companies struggling with the effects of the economic crisis. Based in Los Angeles and New York, Socius Capital Group has managed to cross borders and go beyond the US market in matter of capital. This investment group has sustained the European, Asian and Australian markets. Socius Capital Group has managed to raise up to $300 million in capital since it was created, completing 35 different transactions. When the global economy is struggling to restore balance, there is no better or more efficient recovery plan that Socius Capital Group.

###

Tag Words: socius capital group

Categories: Business

Link To This Press Release:

URL HTML Code